Coming Soon

Public Funding for UCB Celltech

Registration Number FC027218

Much-efficient and cost-effective manufacturing of antibody biotherapeutics employing integrated negative chromatography technology

440,832
2015-07-01 to 2018-06-30
Collaborative R&D
The current platform antibody purification process deployed in the bioprocesing industry becomes less efficient and less cost-effective to match with high titre upstream technologies. Based on previous feasibility studies using model antibodies, the key aim and objective of this project is to investigate negative chromatography based technologies using real industrial feedstocks to dramatically improve the overall process efficiency issue as described above. The market size in the downstream biopharmaceutical processing sector is ca $3 - 5 billions and it is a global market to play. The successful outcomes of this project will bring enormous potential cost benefits to the industry.

Novel Tools for Accelerated Biopharmaceutical Development

60,607
2006-08-01 to 2010-01-31
Collaborative R&D
Awaiting Public Summary

Multispectral Analysis: Improved Tools for Process Optimisation and Formulation

30,386
2006-08-01 to 2009-07-31
Collaborative R&D
Awaiting Public Summary

Get notified when we’re launching.

Want fast, powerful sales prospecting for UK companies? Signup below to find out when we're live.